33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618
    Meeting Abstract

    George, S.; Heinrich, M. C.; Razak, A. R. A.; Chi, P.; Gordon, M. S.; Ganjoo, K. N.; von Mehren, M.; Somaiah, N.; Trent, J. C.; Su, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gandhi, L.; Aufiero Ramirez, K.; Schwarzenberger, P.; Ricciardi, T.; Macri, M. J.; Ryan, A.; More, S.; Venhaus, R. R.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Responses and durability in NSCLC treated with pegilodecakin and anti-PD-1
    Meeting Abstract

    Garon, E. B.; Schneider, J. G.; Wong, D. J. L.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and activity of durvalumab + tremelimumab in immunotherapy (IMT)-retreated advanced NSCLC patients
    Meeting Abstract

    Garon, E. B.; Spira, A. I.; Goldberg, S. B.; Chaft, J. E.; Papadimitrakopoulou, V.; Antonia, S. J.; Brahmer, J. R.; Camidge, D. R.; Powderly, J. D.; Wozniak, A. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of carboplatin with or without nivolumab in first- or second-line metastatic TNBC
    Meeting Abstract

    Garrido-Castro, A. C.; Barry, W. T.; Traina, T. A.; Wesolowski, R.; Tung, N. M.; Keenan, T.; Van Allen, E. M.; Lin, N. U.; Winer, E. P.; Krop, I. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood Cancer Survivor study
    Meeting Abstract

    Novetsky Friedman, D.; Hilden, P.; Moskowitz, C. S.; Howell, R. M.; Weathers, R.; Smith, S. A.; Wolden, S. L.; Tonorezos, E. S.; Mostoufi-Moab, S.; Chow, E. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L) 1 therapy
    Meeting Abstract

    Gandhi, L.; Janne, P. A.; Opyrchal, M.; Ramalingam, S. S.; Rybkin, I. I.; Hafez, N.; Raez, L. E.; Gabrilovich, D.; Wang, F.; Ordentlich, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Response and durability of anti-PD-(L) 1 therapy in never- or light-smokers with non-small cell lung cancer (NSCLC) and high PD-L1 expression
    Meeting Abstract

    Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Mooradian, M.; Lydon, C. A.; Anderson, D.; Tenet, M.; Sauter, J. L.; Mino-Kenudson, M.; Shaw, A. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save